Biology Reference
In-Depth Information
242. Yang Z et al (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recur-
rence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol
18(5):1243-1250
243. Prensner JR et al (2011) Transcriptome sequencing across a prostate cancer cohort identifies
PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol
29(8):742-749
244. Orom UA et al (2010) Long noncoding RNAs with enhancer-like function in human cells.
Cell 143(1):46-58
245. Bejerano G et al (2004) Ultraconserved elements in the human genome. Science
304(5675):1321-1325
246. Derti A et al (2006) Mammalian ultraconserved elements are strongly depleted among seg-
mental duplications and copy number variants. Nat Genet 38(10):1216-1220
247. Calin GA et al (2007) Ultraconserved regions encoding ncRNAs are altered in human leuke-
mias and carcinomas. Cancer Cell 12(3):215-229
248. Licastro D et al (2010) Promiscuity of enhancer, coding and non-coding transcription func-
tions in ultraconserved elements. BMC Genomics 11:151
249. Pennacchio LA et al (2006) In vivo enhancer analysis of human conserved non-coding
sequences. Nature 444(7118):499-502
250. Lujambio A et al (2010) CpG island hypermethylation-associated silencing of non-coding
RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29(48):
6390-6401
251. Scaruf fi P et al (2009) Transcribed-Ultra Conserved Region expression is associated with
outcome in high-risk neuroblastoma. BMC Cancer 9:441
252. Braconi C et al (2011) Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA 108(2):
786-791
253. Mestdagh P et al (2010) An integrative genomics screen uncovers ncRNA T-UCR functions
in neuroblastoma tumours. Oncogene 29(24):3583-3592
254. Roobol MJ, Haese A, Bjartell A (2011) Tumour markers in prostate cancer III: biomarkers in
urine. Acta Oncol 50(Suppl 1):85-89
255. Day JR et al (2011) PCA3: from basic molecular science to the clinical lab. Cancer Lett
301(1):1-6
256. Bussemakers MJ et al (1999) DD3: a new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res 59(23):5975-5979
257. de Kok JB et al (2002) DD3(PCA3), a very sensitive and specific marker to detect prostate
tumors. Cancer Res 62(9):2695-2698
258. Hessels D et al (2003) DD3(PCA3)-based molecular urine analysis for the diagnosis of pros-
tate cancer. Eur Urol 44(1):8-15, discussion 15-16
259. Gopinath SC, Wadhwa R, Kumar PK (2010) Expression of noncoding vault RNA in human
malignant cells and its importance in mitoxantrone resistance. Mol Cancer Res
8(11):1536-1546
260. Mourtada-Maarabouni M et al (2009) GAS5, a non-protein-coding RNA, controls apoptosis
and is downregulated in breast cancer. Oncogene 28(2):195-208
261. Arora R et al (2004) Heterogeneity of Gleason grade in multifocal adenocarcinoma of the
prostate. Cancer 100(11):2362-2366
262. Navin N et al (2011) Tumour evolution inferred by single-cell sequencing. Nature
472(7341):90-94
263. Tomlins SA et al (2007) Integrative molecular concept modeling of prostate cancer progres-
sion. Nat Genet 39(1):41-51
Search WWH ::
Custom Search